Ben Lamm, the billionaire driving an $11.5 billion endeavor to resurrect the woolly mammoth, has united with Anduril founder Palmer Luckey to launch a pioneering venture aimed at engineering bio-enhanced military canines.

The Birth of Warhound

Operating under the radar until now, the newly unveiled enterprise is named Warhound. It merges sophisticated cloning techniques with advanced genetic modifications to forge the next generation of operational working dogs for defense forces. These animals are slated to be integrated with cutting-edge hardware designed by Anduril, including a canine counterpart to its Eagle Eye mixed-reality helmet. In an official statement, Luckey emphasized that man’s best friend deserves man’s best technology.

Warhound successfully emerged from stealth mode with a massive $200 million funding round, achieving a valuation of $1.2 billion. The financing was spearheaded by Sequoia partner Shaun Maguire, alongside a heavy-hitting roster of backers including In-Q-Tel, ARK Invest, Franklin Templeton, 8VC, USIT, Bob Nelsen, Breyer Capital, CAZ Investments, Neogenesis, Builders VC, and Lux Capital.

Origins of a Sci-Fi Vision

Lamm shared that discussions with Luckey originated several years ago backstage at a Moonshot gathering hosted by Peter Diamandis, founder of the XPrize Foundation. Conversations shifted from Colossal’s initiative to revive the dire wolf toward the mounting hurdles associated with sourcing and training elite working dogs.

The vast majority of military dogs are imported from Europe, where supplies are steadily shrinking and competition with global adversaries is fierce, according to Lamm. Once acquired, these animals undergo grueling training regimens where failure rates hover around 55% against rigorous military standards. Tragically, a portion of those that wash out are euthanized.

This is the sci-fi future we were promised. — Ben Lamm

To counter this, Lamm and Luckey devised a strategy to take top-tier military performers, clone them, and genetically enhance their traits—such as mitigating hip dysplasia or sharpening olfactory senses. By doing so, they hope to guarantee a steady stream of animals engineered to successfully pass training and excel in dangerous assignments like explosive detection and search-and-rescue operations.

Fast-Tracked Production and Defense Context

Warhound has already biobanked its initial cell lines and initiated gene editing targeted at these advantageous characteristics. Lamm anticipates producing the first wave of warhounds within the coming months, aiming for operational deployment of their inaugural dog in two years.

The United States Army established its official K-9 Corps back in 1942. Today, the Department of Defense oversees a working dog program encompassing upwards of 2,200 teams, with over 80% of those canines sourced from Europe. Meanwhile, the Air Force allocated $45 million for its own canine program in its 2025 budget.

Following Colossal’s acquisition of animal-cloning specialist Viagen in November 2025, Lamm noted deep expertise in canine genetics. Warhound can take a proven Belgian Malinois—one that has already successfully navigated multiple deployments—and not only replicate it, but upgrade its biological blueprint.

Man’s best friend deserves man’s best tech. — Palmer Luckey

Selective breeding by humans has historically introduced both positive and beneficial mutations as well as detrimental ones, Lamm explained. Warhound aims to excise mutations responsible for muscle atrophy and hip dysplasia while optimizing genes governing agility and longevity. The company is actively collaborating with the American Humane Society on its animal welfare programs.

Leadership and Industry Perspectives

Warhound is led by CEO Dave Spirk, former senior advisor at Palantir and the Department of Defense's inaugural chief data officer. While Lamm maintains an equity stake and sits on the board of directors, Luckey holds no financial stake and does not serve on the board.

Lamm, 44, holds a net worth of $5.7 billion and co-founded Colossal Biosciences alongside Harvard geneticist George Church in 2021. Colossal has since spun off multiple enterprises, including Astromech, an AI-driven evolutionary forecasting firm valued at $3.8 billion as of August. Luckey, 34, amassed his initial fortune through virtual reality pioneer Oculus VR, which he sold to Facebook in 2014 for $2 billion. Currently valued at $5.9 billion, he founded defense tech unicorn Anduril in 2017, which commanded a $61 billion valuation in its May funding round.

Currently, canine recruits—primarily Belgian Malinois, German Shepherds, and Labrador retrievers—are largely procured from international breeders, with roughly 13% born and trained at a military facility in San Antonio, Texas. American-bred dogs can cost up to $9,000, while foreign sources average $5,500, with total training expenditures easily eclipsing $60,000 per animal, per historical reports.

Joshua Morton, founder of Canine Tactical and a former Navy SEAL who established a combat dog program, notes that cloning could theoretically drive down costs by establishing greater biological consistency. He estimates traditional breeding programs yield a meager 10% to 15% success rate per litter in producing dogs capable of meeting strict military thresholds.

However, Morton also warns of potential pitfalls. At its worst, cloning can compound hereditary genetic defects across generations, manifesting either as physical illnesses or behavioral trauma markers that make a dog difficult to train. Only time will tell if these high-tech ventures can successfully navigate the complexities of biological engineering.